WASHINGTON — The Federal Trade Commission wants more information about Walgreens’ $9.41 billion plan to buy rival drugstore chain Rite Aid, a sign that regulators may be concerned about the deal’s impact on competition.
Walgreens said Friday that it fielded a request for additional information beyond what the companies have already been required to provide under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Walgreens said it expected the request.
A former Justice Department attorney said regulators ask for more information when their initial review of a deal suggests that there are “serious competitive concerns.”
